logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 8
  • 1
    Bakri, Rached Sami, Dr
    Entrepreneur born in July 1977
    Individual (4 offsprings)
    Officer
    2024-05-20 ~ 2025-09-26
    OF - Director → CIF 0
  • 2
    Cohen, Laurence John
    Born in September 1951
    Individual (21 offsprings)
    Officer
    2017-11-28 ~ now
    OF - Director → CIF 0
    Mr Laurence John Cohen
    Born in September 1951
    Individual (21 offsprings)
    Person with significant control
    2017-11-28 ~ 2019-09-25
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
  • 3
    Djamgoz, Mustafa Bilgin Ali, Prof
    University Professor born in August 1952
    Individual (8 offsprings)
    Officer
    2017-11-28 ~ 2024-03-24
    OF - Director → CIF 0
    Professor Mustafa Bilgin Ali Djamgoz
    Born in August 1952
    Individual (8 offsprings)
    Person with significant control
    2017-11-28 ~ 2024-11-21
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
  • 4
    Harimohan, Bhavani, Dr
    Born in December 1979
    Individual (1 offspring)
    Officer
    2024-08-26 ~ now
    OF - Director → CIF 0
  • 5
    Rahman, Ajmal
    Financial Consultant born in July 1963
    Individual (17 offsprings)
    Officer
    2020-07-01 ~ 2021-11-08
    OF - Director → CIF 0
  • 6
    Xeniadis, Vasileios, Dr.
    Banker born in July 1965
    Individual (2 offsprings)
    Officer
    2019-09-25 ~ 2020-06-08
    OF - Director → CIF 0
    Dr Vasileios Xeniades
    Born in September 1965
    Individual (2 offsprings)
    Person with significant control
    2019-09-25 ~ 2020-06-08
    PE - Has significant influence or controlCIF 0
  • 7
    Millard, Brian Percival De Thorpe
    Consultant born in April 1943
    Individual (25 offsprings)
    Officer
    2019-09-25 ~ 2020-06-08
    OF - Director → CIF 0
  • 8
    Faltum, Carsten Kronsbjerg
    Born in February 1969
    Individual (2 offsprings)
    Officer
    2019-07-21 ~ now
    OF - Director → CIF 0
parent relation
Company in focus

CELEX ONCOLOGY INNOVATIONS LIMITED

Period: 2017-11-28 ~ now
Company number: 11085607
Registered name
CELEX ONCOLOGY INNOVATIONS LIMITED - now
Standard Industrial Classification
21100 - Manufacture Of Basic Pharmaceutical Products
Brief company account
Average Number of Employees
42024-01-01 ~ 2024-12-31
32023-01-01 ~ 2023-12-31
Intangible Assets
809,420 GBP2024-12-31
700,250 GBP2023-12-31
Property, Plant & Equipment
1,398 GBP2024-12-31
Fixed Assets
810,818 GBP2024-12-31
700,250 GBP2023-12-31
Debtors
Current
20,183 GBP2024-12-31
28,344 GBP2023-12-31
Cash at bank and in hand
1,632,970 GBP2024-12-31
128,201 GBP2023-12-31
Current Assets
1,653,153 GBP2024-12-31
156,545 GBP2023-12-31
Creditors
Current, Amounts falling due within one year
-174,463 GBP2024-12-31
-67,827 GBP2023-12-31
Net Current Assets/Liabilities
1,478,690 GBP2024-12-31
88,718 GBP2023-12-31
Total Assets Less Current Liabilities
2,289,508 GBP2024-12-31
788,968 GBP2023-12-31
Net Assets/Liabilities
2,289,508 GBP2024-12-31
788,968 GBP2023-12-31
Equity
Called up share capital
1,021 GBP2024-12-31
424 GBP2023-12-31
Share premium
3,849,744 GBP2024-12-31
874,513 GBP2023-12-31
Retained earnings (accumulated losses)
-1,561,257 GBP2024-12-31
-85,969 GBP2023-12-31
Equity
2,289,508 GBP2024-12-31
788,968 GBP2023-12-31
Property, Plant & Equipment - Depreciation rate used
Computers
332024-01-01 ~ 2024-12-31
Intangible Assets - Gross Cost
Patents/Trademarks/Licences/Concessions
809,420 GBP2024-12-31
700,250 GBP2023-12-31
Intangible Assets
Patents/Trademarks/Licences/Concessions
809,420 GBP2024-12-31
700,250 GBP2023-12-31
Property, Plant & Equipment - Gross Cost
Computers
1,573 GBP2024-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Computers, Owned/Freehold
175 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Computers
175 GBP2024-12-31
Property, Plant & Equipment
Computers
1,398 GBP2024-12-31
Other Debtors
Current
20,183 GBP2024-12-31
3,827 GBP2023-12-31
Prepayments/Accrued Income
Current
24,517 GBP2023-12-31
Cash and Cash Equivalents
1,632,970 GBP2024-12-31
128,201 GBP2023-12-31
Trade Creditors/Trade Payables
Current
50,578 GBP2024-12-31
9,688 GBP2023-12-31
Other Creditors
Current
120,560 GBP2024-12-31
54,864 GBP2023-12-31
Accrued Liabilities/Deferred Income
Current
3,325 GBP2024-12-31
3,275 GBP2023-12-31
Creditors
Current
174,463 GBP2024-12-31
67,827 GBP2023-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
10,211,800 shares2024-12-31
4,241,457 shares2023-12-31
Par Value of Share
Class 1 ordinary share
0.00012024-01-01 ~ 2024-12-31

  • CELEX ONCOLOGY INNOVATIONS LIMITED
    Info
    Registered number 11085607
    101 New Cavendish Street, 1st Floor South, London W1W 6XH
    PRIVATE LIMITED COMPANY incorporated on 2017-11-28 (8 years 5 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2025-04-05
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.